Overview
Gerold Bepler is an Oncologist practicing medicine in Troy, Michigan.
Dr. Bepler is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.
He is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 2 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
Locations
1560 E Maple Rd, Troy, MI 48083
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Henry Ford Cancer-Detroit
Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.
Oncology Clinic
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 36 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Henry Ford Medical Center-Columbus
Philip Philip is an Oncologist practicing medicine in Novi, Michigan. Dr. Philip is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Liver Embolization, and Pancreatectomy. Dr. Philip is currently accepting new patients.
Frequently Asked Questions about Dr. Gerold Bepler
How do I make an appointment with Dr. Gerold Bepler?
You can book an appointment with Dr. Gerold Bepler by calling their office at 800-527-6266. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gerold Bepler a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gerold Bepler is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gerold Bepler specialize in?
While Dr. Gerold Bepler is a Oncology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Gerold Bepler participate in research or clinical trials?
Yes. Dr. Gerold Bepler has published 55 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Gerold Bepler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gerold Bepler accept my insurance?
Dr. Gerold Bepler accepts most major insurance plans, including Blue Cross Blue Shield and CareFirst. We recommend calling the office directly at 800-527-6266 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Bepler isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Bepler isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Bepler isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Bepler isExperienced. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Bepler isExperienced. Learn about Small Cell Lung Cancer (SCLC).

